Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Seres Therapeutics showcased promising Phase 1b data for its investigational live biotherapeutic SER-155 at the ESCMID Global 2026 congress. The data revealed significant and durable changes in GI microbiome composition leading to improved gastrointestinal epithelial barrier integrity in patients undergoing allogeneic hematopoietic cell transplanta…
Brady Corporation announced the acquisition of Honeywell's Productivity Solutions and Services (PSS) business in an all-cash transaction valued at approximately $1.4 billion. The acquisition expands Brady’s product portfolio into leading-edge mobility, scanning, and software solutions that serve enterprise customers in logistics, manufacturing, war…
Monte Rosa Therapeutics presented preclinical data at the AACR 2026 Annual Meeting showcasing the potential of MRT-55811, a first-in-class cyclin E1 (CCNE1)-directed molecular glue degrader. The compound demonstrated strong tumor regression in CCNE1-amplified models of ovarian, breast, and gastric cancers with superior selectivity and reduced off-t…
NRx Pharmaceuticals welcomes President Trump's Executive Order aimed at accelerating the development and approval of psychedelic medications for treating serious mental illnesses such as depression, PTSD, and suicidality. The company’s drug candidate NRX-100 has received FDA Fast Track designation and anticipates submitting a New Drug Application w…
Kustom Entertainment, Inc. declared a 1-for-5 reverse stock split of its common stock effective April 22, 2026, to raise its share price above Nasdaq's $1.00 minimum requirement. The reverse split includes a proportional reduction in authorized common shares, aiming to ensure continued listing on Nasdaq. The company specializes in advanced video re…
The U.S. Food and Drug Administration has assigned priority review to two supplemental Biologics License Applications from Merck for KEYTRUDA and KEYTRUDA QLEX, each in combination with Padcev, targeting muscle-invasive bladder cancer patients eligible for cisplatin-based chemotherapy. The filings are supported by Phase 3 KEYNOTE-B15 data that show…
Raymond James found that most Canadian energy stocks lagged the WTI commodity strip and the TSX between Feb. 27 and Apr. 17, with nearly 60% of names posting negative total returns. The firm says exploration and integrated companies are trading at double-digit sustaining free cash flow yields at $70 WTI and continues to favor a basket of large-cap …
Shipping through the Strait of Hormuz was effectively frozen on Monday, with only three transits recorded in a 12-hour window. Satellite analysis and vessel-tracking platforms identified an oil products tanker leaving the Gulf and two vessels entering it, while geopolitical tensions rose after a U.S. seizure of an Iranian cargo ship and Tehran's vo…
Pharvaris announced presentation of clinical data supporting the safety of combined use of deucrictibant immediate-release capsules and extended-release tablets for prophylactic and on-demand treatment of bradykinin-mediated angioedema, including hereditary angioedema (HAE). The data suggest adequate safety margins and potential efficacy for this c…
Greenwich LifeSciences saw its shares climb more than 4% in premarket trading Monday after reporting that its GLSI-100 vaccine produced a stronger immune response in participants of the late-stage FLAMINGO-01 study. The trial, which evaluates the vaccine's capacity to prevent breast cancer from returning following standard treatment, reported marke…
Barclays adjusted its coverage on several large European banks, lowering Deutsche Bank while upgrading Commerzbank, UBS and Julius Baer. The moves reflect a delayed German GDP acceleration, UniCredit’s bid-related floor for Commerzbank shares, and reduced Credit Suisse integration risk at UBS, alongside updated earnings per share forecasts and capi…
Shares of companies developing psychedelic therapies climbed in premarket trading after President Donald Trump signed an executive order directing federal health regulators to expedite reviews of psychedelic treatments and to increase federal research funding for ibogaine. The order could significantly shorten FDA review timelines for qualifying dr…
Markets opened the week with renewed uncertainty after Iran reversed course over the weekend and again restricted passage through the Strait of Hormuz, following a brief reopening on Friday. The episode, in which Iranian forces fired on tankers and the United States seized an Iranian cargo ship, left traders questioning what, if anything, had been …
B2Gold Corp. announced the sale of its 70% interest in the Fingold Ventures Ltd. joint venture to Agnico Eagle Mines Limited for US$325 million in cash. Alongside this transaction, the companies have agreed to collaborate on gold mining operations in Nunavut, Canada, aiming to share expertise and improve operational efficiencies in arctic environme…
Becton, Dickinson (BDX) looks comfortably priced against its cash flow and dividend pedigree, but the market is still demanding proof of a durable earnings re-acceleration. This trade plan buys into recurring consumables revenue and FCF strength while protecting capital with a tight stop and a near-term target tied to mean reversion toward prior re…
Silo Pharma highlights its lead program, SPC-15, an intranasal serotonin 4 receptor agonist targeting prophylactic treatment of PTSD, coinciding with President Trump's executive order accelerating psychedelic therapy research. SPC-15 benefits from rapid nose-to-brain delivery and a streamlined regulatory pathway, positioning the company to leverage…
UBS analyst Nicolas Le Roux says commodity trading advisers (CTAs) are positioned to sharply increase their exposure to U.S. equity futures in the coming weeks, potentially quadrupling S&P 500 exposure by the end of April even if prices do not move higher. The bank's simulation shows divergent CTA behavior across regions and asset classes, includin…
India's key equity benchmarks closed higher on Monday, with the Nifty 50 edging up 0.05% to a one-month high and the BSE Sensex 30 rising 0.03%. Strength in Power, Capital Goods and Public Sector Undertakings stocks underpinned the move, even as decliners outnumbered advancers across both exchanges and market volatility rose.
Prelude Therapeutics, a clinical-stage precision oncology company, announced the pricing of an underwritten offering of approximately 18 million shares of common stock and pre-funded warrants to raise gross proceeds of about $90 million. The offering, led by RA Capital Management and participated by other healthcare-focused investors, is expected t…
KANZHUN LIMITED (BOSS Zhipin), a company listed on Nasdaq and Hong Kong stock exchanges, announced April 17th repurchases of 349,698 shares using RMB17.0 million. Year-to-date 2026, the company has invested over RMB913 million in repurchasing shares, reiterating its dedication to enhancing shareholder value.
Kevin Warsh, President Donald Trump's nominee to lead the U.S. central bank, will appear before the Senate Banking Committee for a confirmation hearing where senators are expected to press him on his monetary policy views, commitment to Fed independence, and his actions during the 2007-2009 financial crisis. The hearing comes amid partisan friction…
U.S. equity benchmarks rallied Friday after Iran declared the Strait of Hormuz "completely open" following a ceasefire announcement between Israel and Lebanon, lifting the S&P 500, Nasdaq and Dow to new record closes as oil prices slid. The move capped a strong week for stocks, but volatility returned after renewed tensions over the weekend. Trader…
Tesla’s solar and energy arm is expected to outperform the automaker’s shrinking vehicle business in the coming quarterly results, providing some relief as the company spends heavily on new factories and robotics. While vehicle profitability and regulatory credit revenues have fallen, the energy division is expanding faster and is materially more p…
Tesla’s 2025 U.S. federal tax bill was reported as zero in its January filing. Beyond historical losses and clean-energy credits, a review of corporate filings indicates subsidiaries in the Netherlands and Singapore recorded about $18 billion of profits in recent years that were not taxed in those jurisdictions - profits that otherwise may have bee…
The U.S. Supreme Court will hear arguments over the Securities and Exchange Commission’s ability to obtain disgorgement - the recovery of profits tied to unlawful conduct. The case centers on whether the SEC must demonstrate that victims suffered pecuniary harm before courts can order the return of ill-gotten gains, a question raised by the appeal …
